BNP Paribas Financial Markets
CALC icon

BNP Paribas Financial Markets’s CalciMedica CALC Stock Holding History

BNP Paribas Financial Markets’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$2 – 5932
2026
Q1 		$2 Sell
3
-16
-84% -$32 ﹤0.01% 5791
2025
Q4 		$125 Hold
19
– – ﹤0.01% 5597
2025
Q3 		$58 Hold
19
– – ﹤0.01% 5465
2025
Q2 		$30 Buy
+19
New +$33 ﹤0.01% 5376
2022
Q4 		– Sell
-8
Closed -$107 – 4134
2022
Q3 		$107 Buy
+8
New +$113 ﹤0.01% 4641

Other funds holding CALC

LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BNP Paribas Financial Markets's CALC Position: Q2 2026 in Review

BNP Paribas Financial Markets sold out of CalciMedica (CALC) in Q2 2026, closing a stake of 3 shares — an estimated $2 sold.

BNP Paribas Financial Markets first reported a position in CALC in Q3 2022 and held it in 5 quarters. The position peaked at $125 in Q4 2025. 19 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • BNP Paribas Financial Markets reported no remaining CalciMedica position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 3 CalciMedica shares in Q2 2026, an estimated $2.
  • BNP Paribas Financial Markets first reported a position in CalciMedica in Q3 2022 and held it in 5 quarters.
  • BNP Paribas Financial Markets's CalciMedica position peaked at $125 in Q4 2025.
  • 19 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.